Zech D, Radbruch L, Grond S, Heise W
Klinik für Anaesthesiologie und Operative Intensivmedizin, Universität zu Köln, Joseph-Stelzmann-Straße 9, D-50924, Köln.
Schmerz. 1994 Jun;8(2):119-24. doi: 10.1007/BF02530417.
The number of AIDS patients is steadily increasing. According to the literature these patients are often in severe pain.
We evaluated pain diagnoses and treatments with two almost identical questionnaires for AIDS treatment units (ATU) and pain management units (PMU). Questions dealt with unit type and size, number of patients treated per year and the proportion of intravenous drug users. The units were also asked to give an estimate of pain aetiologies, pain types and localizations and treatment modalities offered.
Completed questionnaires were returned by 38 of 235 ATU and 85 of 127 PMU. In the ATU, 16% of the patients (estimated at 580 patients per year) had pain requiring treatment. In 26 of the PMU approximately 120 AIDS patients per year were treated, while 59 PMU had not yet seen any AIDS patients. Pain was caused mainly by opportunistic infections and by neurological syndromes connected with AIDS. Pain aetiologies could not be differentiated in the ATU in 22% of patients (PMU 9%), and pain types in 33% (PMU 9%). Neuropathic pain (ATU 38%, PMU 89%) was more frequent than nociceptive pain (ATU 29%, PMU 36%). The treatment modalities were systemic pharmacotherapy in 76% of ATU and 73% of PMU and nerve blocks in 37% of ATU and 42% of PMU. In 82% of ATU the staff thought their analgesic therapy was adequate, and in 92% staff were interested in closer cooperation with PMU such as was currently practised in only 6 of the 38 units (16%) that responded.
The high incidence of complicated neuropathic pain syndromes in AIDS patients requires a sophisticated therapeutic approach. Closer cooperation between AIDS specialists and pain specialists, comparable to that already existing for other patient groups, is therefore desirable.
艾滋病患者的数量正在稳步增加。根据文献记载,这些患者常处于剧痛之中。
我们使用两份几乎相同的问卷,对艾滋病治疗单位(ATU)和疼痛管理单位(PMU)的疼痛诊断与治疗情况进行评估。问题涉及单位类型与规模、每年治疗的患者数量以及静脉吸毒者的比例。各单位还被要求对疼痛病因、疼痛类型与部位以及所提供的治疗方式进行估计。
235个ATU中的38个以及127个PMU中的85个返回了完整问卷。在ATU中,16%的患者(估计每年580例患者)有需要治疗的疼痛。在26个PMU中,每年约治疗120例艾滋病患者,而59个PMU尚未见过任何艾滋病患者。疼痛主要由机会性感染以及与艾滋病相关的神经综合征引起。在ATU中,22%的患者(PMU为9%)无法区分疼痛病因,33%(PMU为9%)无法区分疼痛类型。神经性疼痛(ATU为38%,PMU为89%)比伤害性疼痛(ATU为29%,PMU为36%)更常见。治疗方式方面,76%的ATU和73%的PMU采用全身药物治疗,37%的ATU和42%的PMU采用神经阻滞。在82%的ATU中,工作人员认为他们的镇痛治疗是充分的,92%的工作人员有兴趣与PMU进行更密切的合作,而在回复的38个单位中只有6个(1)目前正在开展此类合作。
艾滋病患者中复杂神经性疼痛综合征的高发病率需要复杂的治疗方法。因此,艾滋病专家和疼痛专家之间需要更密切的合作,这与其他患者群体现有的合作类似。